alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Cancer of Kidney in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and has the highest propensity to manifest as metastatic disease." | 1.40 | Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. ( Anastasiadis, PZ; Cooper, SJ; Copland, JA; Grebe, SK; Marlow, LA; Radisky, DC; Tun, HW; von Roemeling, CA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Roemeling, CA | 1 |
| Radisky, DC | 1 |
| Marlow, LA | 1 |
| Cooper, SJ | 1 |
| Grebe, SK | 1 |
| Anastasiadis, PZ | 1 |
| Tun, HW | 1 |
| Copland, JA | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cancer of Kidney
| Article | Year |
|---|---|
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; C-Reactive Protein; Carcinoma, Renal Cell; | 2014 |